Evidence map›Paper›PMID 24772123›Full record

ArticlePakistan journal of medical sciences2014

Ameliorative effect of melatonin against contrast media induced renal tubular cell injury.

Hamid Nasri, Maryam Tavakoli, Ali Ahmadi, Azar Baradaran, Mehdi Nematbakhsh, Mahmoud Rafieian-Kopaei

Open access · hybridAbstract read
In one paragraph

Article in Pakistan journal of medical sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Melissa officinalis L: A Review Study With an Antioxidant Prospective.Journal of evidence-based complementary & alternative medicine · 2017
    Review
  6. Cancer Phytotherapy: Recent Views on the Role of Antioxidant and Angiogenesis Activities.Journal of evidence-based complementary & alternative medicine · 2017
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. New concepts in nutraceuticals as alternative for pharmaceuticals.International journal of preventive medicine · 2014
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hamid NasriHamid Nasri, Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran.
Maryam TavakoliMaryam Tavakoli, Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Ali AhmadiAli Ahmadi, Department of Epidemiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Azar BaradaranAzar Baradaran, Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.
Mehdi NematbakhshMehdi Nematbakhsh, Water and Electrolytes, Research Center, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran.
Mahmoud Rafieian-KopaeiMahmoud Rafieian-Kopaei, Medical Plants Research Center, Shahrekord University of Medical Sciences, Sharekord, Iran.
Isfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveReactive oxygen species (ROS) is a mediator of renal damage. Melatonin is a potent-free radical scavenger. Our objective was to test whether melatonin would protect against the nephrotoxicity of contrast media.

methodsIn an experimental study 40 adult male Wistar rats were randomly divided into four equal groups including: 1) Control group (No drug), 2) Contrast media group (10 ml/kg iodixanol i.v. single dose), 3) Contrast media and melatonin (first 10 ml/kg iodixanol then 10 ml/kg/day melatonin by i.p. injection on days 3, 4 and 5) and 4) Contrast media and melatonin pretreatment group (melatonin 10 ml/ kg/day by i.p. injection on 1, 2 and 3 days, then 10 ml/kg iodixanol by i.v. injection on third day. The blood creatinine and BUN as well as the histological changes were evaluated for severity of renal injury (degeneration, vacuolization of tubular renal cells, dilatation of tubular lumen and presence of debris in the lumens), by scoring from one to four.

resultsContrast media significantly increased the creatinine and BUN and renal injury (p<0.05). Melatonin prevented and reversed the injury induced by contrast media (P<0.05). Pretreatment with melatonin reduced the renal injury induced by contrast media (P<0.05).

conclusionMelatonin is an effective drug to prevent contrast-induced renal injury. Therefore its usage (especially pretreatment) might be beneficial in patients who are planning to use contrast media agents.

Indexed as

Contrast-induced nephropathyContrast mediaIodixanolMelatoninReactive oxygen speciesRenal failure

Identifiers

PMID24772123
PMCPMC3998990
OpenAlexW2335514473

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.